Effects of propofol on hypoxia/reoxygenation induced neuronal cell damage in vitro. by Huang, Ying
  
 
 
Aus der Klinik für Anästhesiologie und Operative Intensivmedizin 
(Direktor: Prof. Dr. med. Markus Steinfath) 
im Universitätsklinikum Schleswig-Holstein, Campus Kiel 
an der Christian-Albrechts-Universität zu Kiel 
 
 
 
 
 
 
 
EFFECTS OF PROPOFOL ON HYPOXIA/REOXYGENATION 
INDUCED NEURONAL CELL DAMAGE IN VITRO 
 
 
 
 
 
 
 
 
Inauguraldissertation 
zur 
 Erlangung der Doktorwürde 
der Medizinischen Fakultät 
der Christian-Albrechts-Universität zu Kiel 
 
 
 
 
 
 
 
 
 
vorgelegt von 
 
Ying Huang 
 
aus Wuhan, Hubei, Volksrepublik China 
 
 
 
 
 
Kiel 2013 
 
 
  
 
 
Aus der Klinik für Anästhesiologie und Operative Intensivmedizin 
(Direktor: Prof. Dr. med. Markus Steinfath) 
im Universitätsklinikum Schleswig-Holstein, Campus Kiel 
an der Christian-Albrechts-Universität zu Kiel 
 
 
 
 
 
 
 
EFFECTS OF PROPOFOL ON HYPOXIA/REOXYGENATION 
INDUCED NEURONAL CELL DAMAGE IN VITRO 
 
 
 
 
 
 
 
 
Inauguraldissertation 
zur 
 Erlangung der Doktorwürde 
der Medizinischen Fakultät 
der Christian-Albrechts-Universität zu Kiel 
 
 
 
 
 
 
 
 
 
vorgelegt von 
 
Ying Huang 
 
aus Wuhan, Hubei, Volksrepublik China 
 
 
 
 
 
Kiel 2013 
 
 
  
Parts of this work have been published: 
 
1. Huang Y, Zitta K, Bein B, Scholz J, Steinfath M, Albrecht M. (2012) Effects of propofol on 
hypoxia re-oxygenation induced neuronal cell damage in vitro. Anaesthesia. Oct 22. doi: 
10.1111/j.1365-2044.2012.07336.x. [Epub ahead of print]  
 
2. Zitta K, Meybohm P, Bein B, Huang Y, Heinrich C, Scholz J, Steinfath M, Albrecht M. 
(2012) Salicylic acid induces apoptosis in colon carcinoma cells grown in vitro: influence of 
oxygen and salicylic acid concentration. Exp Cell Res. Apr 15;318(7):828-34. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Berichterstatter: Priv. Doz. Dr. Martin Albrecht 
2. Berichterstatter: Prof. Dr. med. Feldkamp 
Tag der mündlichen Prüfung: 11.7.2013 
Zum Druck genehmigt, Kiel, der Medizinischen Fakultät der Christian-Albrechts-Universität zu 
Kiel am 12.7.2013 
gez: Ying Huang
 
 
1 
 
Contents 
 
Contents .................................................................................................................1 
 
Abbreviations .........................................................................................................3 
 
1. Introduction .....................................................................................................5 
 
1.1.   Hypoxia/reoxygenation ....... ..... .... ..... ..... .... ..... . .... ..... .... ..... ..... ..... .. ....... ....... ....5 
 
1.1.1. Cell damage .........................................................................................................5 
 
1.1.2.   Two-enzyme hypoxia model ............................................(2003)........................5 
 
1.2.  Reactive oxygen species .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 
 
1.3. Antioxidant and neuroprotective effects of propofol ............................................7 
 
1.4. Cellular antioxidant mechanisms .....................................................................................8 
 
2. Materials and methods ................................................................................10 
 
2.1. Materials .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 
 
2.1.1. Oligonucleotides ............................................................................................ . 10 
 
2.1.2. Enzymes ........................................................................................................ . 10 
 
2.1.3. Antibodies ...................................................................................................... .10 
 
2.1.4. Kits and assays .............................................................................................. .10 
 
2.1.5. Cells ...............................................................................................................11 
 
2.1.6. Chemicals and reagents ................................................................................11 
 
2.1.7. Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 
 
2.1.8. Consumables ..................................................................................................13 
 
2.1.9. Instruments ......................................................................................................13 
 
2.1.10. Software ......................................................................................................... .14 
 
2.2. Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 
 
2.2.1. Experimental setting .......................................................................................14 
 
2.2.2. Cell culture .................................................................................................. 15 
 
2.2.3.     Reverse transcription polymerase chain reaction (RT-PCR) ............................16 
 
2.2.3.1. RNA extraction ......................................................................................... 16 
 
2.2.3.2. Reverse transcription...............................................................................16 
 
2.2.3.3. Polymerase chain reaction .......................................................................16 
  
2.2.4.   Cytotoxicity assay .................................................................................................17 
 
2.2.5.   Western blotting ................................................................................................. 17 
 
2.2.5.1. Total protein extraction and quantification ...............................................17 
 
2.2.5.2. Electrophoresis .................................................................................. 17 
 
2.2.5.3. Transfer ....................................................................................................18 
 
2.2.5.4. Blocking and antibody incubation .......................................................18 
 
2.2.6.   H2DCFDA assay .................................................................................................18  
2.2.7.   Hydrogen peroxide assay .................................................................................19 
 
2.2.8.   Catalase activity assay ........................................................................................19 
 
 
 
2 
 
2.2.9.   Statistics ................................................................................................................19 
 
3. Results ...........................................................................................................21 
 
3.1. Induction of in vitro hypoxia ...............................................................................21 
 
3.2. Effects of propofol on hypoxia induced cell damage ......................................21 
 
3.3. Effects of propofol on hypoxia induced generation of reactive oxygen species ......23 
 
3.4. Effects of propofol on hypoxia induced generation of hydrogen peroxide ...........23 
 
3.5. Effects of propofol on hypoxia regulated expression and activity of catalase ....24 
 
4. Discussion ....................................................................................................26 
 
4.1. Induction of in vitro hypoxia .....................................................................................26 
 
4.2. Effects of propofol on hypoxia induced cell damage ..................................26 
 
4.3. Effects of propofol on hypoxia induced generation of reactive oxygen species 
          
and hydrogen peroxide ............................................................................27 
 
4.4. Effects of propofol on hypoxia regulated expression and activity of catalase ............28 
 
5.  Summary .....................................................................................................29 
 
6.  References ...............................................................................................30 
 
7.  Appendix ...............................................................................................36 
 
8.  Acknowledgements .......................................................................................38 
 
9.  Curriculum vitae .........................................................................................39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
Abbreviations 
                                                                                      
APS              Ammonium persulfate 
ATP Adenosine-5'-triphosphate 
BSA              Bovine serum albumin 
Bcl-2               B-cell lymphoma 2 
Bax                Bcl-2-associated X protein 
cDNA 
CM-H2DCFDA 
CAT 
Complementary DNA 
6-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate 
Catalase 
DCF 
DD water 
DEPC water 
Dichlorofluorenscein 
Double-distilled water 
Diethylpyrocarbonate water 
DMEM 
DMEM/F12 
Dulbecco’s modified eagle medium 
Dulbecco's modified eagle's medium/ nutrient mixture F12 
DMSO          Dimethyl sulfoxide 
DNA  Deoxyribonucleotide acid 
dNTP            Deoxy-ribonucleoside triphosphate 
EDTA             Ethylenediaminetetraacetic acid 
e.g.              Exempli gratia 
ELISA 
ECL 
Enzyme linked immunosorbent assay 
Enhanced chemiluminescence 
FCS 
For 
Fetal calf serum 
Forward 
GPX                                    
GABAA 
GSH 
GSSG 
Glutathione peroxidase 
Gamma-aminobutyric acid receptor A 
Glutathione 
Glutathione disulfide 
HCl            Hydrogen chloride 
H2DCFDA 2',7'-dichlorodihydrofluorescein diacetate 
HRP Horseradish peroxidase 
IMR-32 
IgG 
Human neuroblastoma cells 
Immunoglobulin G 
L                   Liter 
LDH              Lactate dehydrogenase 
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M                  Mol 
mM             Millimol 
min              Minute 
ml               Milliliter 
mRNA 
NF-κB 
NP-40 
Messenger RNA 
Nuclear factor kappa-light-chain-enhancer of activated B cells 
Tergitol-type NP-40 
ng Nanogram 
nm Nanometer 
O2               Oxygen 
PARP 
PBS 
PKB 
Poly ADP-ribose polymerase 
Phosphate buffered saline 
Protein kinase B 
PCR            Polymerase chain reaction 
pH              Potential of hydrogen 
PVDF membrane 
Rev 
Polyvinylidene-fluoride membrane 
Reverse 
RIPA buffer           Radio-immunoprecipitation assay buffer 
RNA 
RNase inhibitor 
Ribonucleic acid 
Ribonuclease inhibitor 
RPMI-1640       Roswell park memorial institute-1640 
RT-PCR          Reverse transcription polymerase chain reaction 
S.D. 
SDS 
SDS-PAGE 
Standard deviation 
Sodium dodecyl sulfate 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SOD           Superoxide dismutase 
TEMED 
TBST buffer 
Tween20 
Tetramethylethylendiamine 
Tris-buffered saline and tween 20 buffer 
Polyoxyethylene (20) sorbitan monolaurate 
μg Microgram 
μl                                              Microliter 
μM                  Micromol
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1. Introduction 
 
1.1. Hypoxia/reoxygenation 
 
1.1.1. Cell damage 
Hypoxia/reoxygenation is a common physiological stress which widely occurs under various 
clinical conditions such as circulatory shock, myocardial ischemia, stroke, transplantation of 
organs (Levinson et al. 1986, McCord 1985) and brain injury (Cazevieille et al. 1993). 
Hypoxia/reoxygenation via different pathological pathways causes cell damage. Typical 
pathways include induction of inflammation primarily mediated by the NF-κB (Fabiano et al. 
2008), loss of mitochondrial cytochrome C, activation of various apoptosis-associated factors 
such as bcl-2, bax, pro-caspase-3, active-caspase-3 and generation of reactive oxygen species 
which is one of the most important triggers of hypoxia/reoxygenation induced cell damage 
(Torre-Bouscoulet et al. 2008). 
Reactive oxygen species generated during hypoxia/reoxygenation can induce cell death via 
necrosis or apoptosis (Tan et al. 1998). Recently, antioxidants have been reported to inhibit DNA 
fragmentation and PARP cleavage, which implies that the inhibition of reactive oxygen species 
by antioxidants might play a crucial role in the attenuation of hypoxia/reoxygenation induced 
cell damage (Mizukami et al. 2000). 
In the brain, hypoxia/reoxygenation events can result in various pathological processes including 
oxidative and inflammatory stress (Lim et al. 2010) and often lead to severe cellular damage 
which causes neurological dysfunction and poor clinical outcome (Hamm et al. 1990, 
Obrenovitch et al. 1988, Schlaepfer 1987, Semenza 2000). Cerebral neurons can tolerate at least 
20 min of ischemic hypoxia under normothermic condition. However, in the clinic, cerebral 
recovery is often counteracted by complex secondary dysfunctions of multiple organ systems 
after reoxygenation (Safar 1986). The underlying mechanisms of hypoxia/reoxygenation injury 
in the brain are multifactorial and complex, but recent studies point towards a crucial role of 
reactive oxygen species which are generated during the process of hypoxia/reoxygenation (Wang 
et al. 2010) and may damage cellular macromolecules by lipid peroxidation, oxidation of 
proteins as well as inhibition of specific enzymes by oxidation of co-factors (Elahi et al. 2009).  
 
1.1.2. Two-enzyme hypoxia model 
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The investigation of intracellular pathways and mechanisms during hypoxia/reoxygenation 
induced cell damage in vivo is of clinical importance, but technically difficult. Cellular models 
of hypoxia/reoxygenation are considered as an effective method to study the mechanisms of 
reactive oxygen species mediated cell damage in hypoxia/reoxygenation injury (Watkins et al. 
1995). In the present study, we employed an in vitro two-enzyme hypoxia model in combination 
with human neuronal cells (IMR-32) to mimic hypoxia/reoxygenation (Zitta et al. 2010a, Zitta et 
al. 2010b). This model is based on two enzymatic reactions (Baumann et al. 2008) (Fig.1). In 
reaction 1, glucose oxidase catalyzes the oxidation of glucose consuming the oxygen in the 
culture medium. In reaction 2, catalase converts the produced hydrogen peroxide from reaction 1 
to water and oxygen. 
 
 
 
Figure 1: Generation of hypoxia using the two-enzyme system. 
The two-enzyme hypoxia system offers a unique opportunity to control oxygen levels in cell 
culture. Moreover, the reactants involved in the enzymatic system are derived from either 
physiological products (water, glucose) or physiological intermediate products (gluconic acid), 
which are common components in all cell culture medium (Mueller et al. 2009). 
1.2. Reactive oxygen species  
Reactive oxygen species are intracellular factors which are associated with the immune system 
and cell signaling. However, excessive reactive oxygen species are destructive and lead to cell 
damage and are also involved in various diseases such as heart disease, Alzheimer’s disease, 
Parkinson’s disease and tumors (Tabner et al. 2001).  
Generation of reactive oxygen species is a crucial event in hypoxia/reoxygenation induced 
neurologic damage. Reactive oxygen species such as the peroxide (·O2-2), the superoxide anion 
(·O2–), and the hydroxyl radical (·OH) are oxidants which structures include unpaired electrons 
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(Jambunathan 2010) (Fig.2). This unstable structure can accept electrons from other molecules 
by oxidation. 
Reactive oxygen species are involved in reduction and oxidation reactions between cellular and 
sub-cellular components and induce damage to membranes, proteins and DNA (Mohsenzadegan 
et al. 2012). Lipids are the major target of intracellular reactive oxygen species, which cause an 
oxidation of polyunsaturated fatty acids in cellular membranes and initiate lipid peroxidation 
(Humphries et al. 1998). In addition, intracellular reactive oxygen species also directly attack 
both the base and the sugar moieties of DNA molecules resulting in DNA damage (Sies 1993) 
and induce deleterious modifications in proteins such as oxidation of sulfhydryl groups and 
amino acid (Fucci et al. 1983, Grune et al. 1997). 
 
Molecular structure of reactive oxygen species and oxygen
 
 
 
Figure 2: Molecular structures of reactive oxygen species and oxygen. Red points denote unpaired electrons. 
 
 
1.3. Antioxidant and neuroprotective effects of propofol 
Reactive oxygen species mediated oxidative stress plays an important part in 
hypoxia/reoxygenation induced cell damage. The intravenous anaesthetic, propofol, has been 
shown to protect different cells from oxidative damage (Vasileiou et al. 2009). Numerous studies 
have shown antioxidant effects of propofol which are possibly mediated via a phenolic hydroxyl 
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group leading to structural similarities between propofol and the natural antioxidant vitamin E 
(Ansley et al. 1998) (Fig.3).  
Propofol (2,6-diisopropylphenol)
The α-tocopherol form of vitamin E
OH
Phenolic hydroxyl group
(CH3)2HC CH(CH3)2
Phenolic 
hydroxyl group
HO
CH3
CH3
H3C
O CH3
[(CH2)3CHCH3]3CH3
 
Figure 3: Chemical structure of propfol and the α-tocopherol form of vitamin E. 
Propofol has been shown to protect neuronal cells from hypoxia/reoxygenation induced damage 
as well (Vasileiou et al. 2009). Yamaguchi et al. reported that propfol protects CA1 pyramidal 
cells from death by attenuating the generation of malondialdehyde which is a marker of lipid 
peroxidation (Yamaguchi et al. 2000). Other studies showed that propofol reduces the brain 
electric activity and consumption of ATP by activating GABAA receptors (Concas et al. 1991, 
Orser et al. 1994, Williams et al. 2002). 
Nevertheless, the detailed antioxidative and neuroprotective mechanisms of propofol are a wide 
spectrum of opinions and still under discussion. 
1.4. Cellular antioxidant mechanisms 
The increase of reactive oxygen species is usually accompanied by an activation of the 
antioxidant defense system (Droge 2002, Ferreira et al. 2004, Vassalle et al. 2008). Cellular 
peroxidases such as superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase 
(CAT) are the most important components of the cellular antioxidant system (Fig.4). 
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CAT
 
Figure 4: Cellular enzymatic antioxidant system: the superoxide anion (·O2–), hydrogen peroxide (H2O2) and the hydroxyl radical 
(·OH) cause damage to membranes, proteins and DNA. Dismutation of superoxide anion generated in mitochondria is catalyzed 
by superoxide dismutase (SOD). The produced hydrogen peroxide is converted to water and oxygen by glutathione peroxidase 
(GPX) and catalase (CAT). Taken and modified from van Golen et al. 2012. 
Superoxide dismutase is one of the major intracellular antioxidant enzymes in animals, plants 
and in the human system. Superoxide dismutase is regarded as the scavenger of intracellular 
reactive oxygen species. According to the metal cofactors, superoxide dismutase can be 
classified into three groups: Cu/Zn-SOD, Mn-SOD and Fe-SOD (Mandryk et al. 2007). 
Glutathione peroxidase is an enzyme with peroxidase activity, which also plays an 
important role in protecting cells from oxidative stress. Glutathione peroxidase catalyzes 
the conversion of glutathione (GSH) to glutathione disulfide (GSSG) and converts toxic 
peroxides into non-toxic hydroxyl compounds simultaneously (Williams et al. 1998). 
Catalase accounts for 40% of the total amount of peroxidases and is one of the most efficient 
enzymes described so far. One molecule of catalase catalyzes the conversion of millions of 
molecules of hydrogen peroxide to water and oxygen per second. (Putnam et al. 2000). 
Besides the above mentioned cellular enzymatic antioxidant system, non-enzymatic system also 
prevents cells from oxidative stress. Members of these natural antioxidants are vitamin A, C, E 
and bilirubin (Fang et al. 2002). 
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2. Materials and methods 
 
2.1. Materials 
 
2.1.1. Oligonucleotides 
Oligonucleotides were synthesized by Metabion (Martinsried, Germany) 
Oligonucleotide         Sequence                              Annealing temperature                                  
Catalase For  
Catalase Rev  
Bax For  
Bax Rev  
Bcl-2 For  
Bcl-2 Rev  
Caspase-3 For  
Caspase-3 Rev  
18S rRNA For 
18S rRNA Rev 
5′-AGCTGGTTAATGCAAATGGG-3′               55°C 
5′-TCTGTTCCTCATTCAGCAC-3′ 
5’-GGGCCCTTTTGCTTCAGGGGA-3’             62°C 
5’-CTGGGGGCCTCAGCCCATCT-3’ 
5’-AGCACCGCTTGGTGTGGCTC-3’              62°C 
5’-GGCACTTGTGGCGGCCTGAT-3’ 
5’-AGTGCTCGCAGCTCATACCT-3’               55°C 
5’-TCAACCTTGTCGGCATACTG-3’ 
5′-GTTGGTGGAGCGATTTGTCTGG-3′            58°C 
5′-AGGGCAGGGACTTAATCAACGC-3′ 
 
2.1.2. Enzymes 
Enzyme                                   Manufacturer                           
Catalase 
Glucose oxidase  
DNA Taq Polymerase  
Sigma-Aldrich, Schnelldorf, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
Solis BioDyne, Tartu, Estonia 
 
2.1.3. Antibodies 
Antibody                                  Manufacturer                            
Anti-catalase IgG (1:15,000)  
Anti-caspase-3 IgG (1:1,000)  
β-actin (1:200)  
Anti-rabbit IgG-HRP (1:10,000) 
Anti-goat IgG-HRP (1:2,000)  
Abcam, Cambridge, UK  
Santa Cruz, Heidelberg, Germany  
Santa Cruz, Heidelberg, Germany 
Dako, Hamburg, Germany  
Santa Cruz, Heidelberg, Germany
 
2.1.4. Kits and assays 
Kit or assay                                Manufacturer                           
Cytotoxicity detection kit  
cDNA reverse transcription kit  
Roche, Mannheim, Germany  
Applied Biosystems, California, USA 
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Qiagen RNeasy mini kit 
QuantiChromTM peroxide assay kit 
Roti®-Quant assay 
ECL kit 
Qiagen GmbH, Hilden, Germany 
BioAssay Systems, Hayward, USA 
Carl Roth GmbH, Karlsruhe, Germany 
Amersham Pharmacia Biotech, Piscataway,
                                          USA 
2.1.5. Cells 
For propagation, human neuroblastoma cells IMR-32 (LGC Standards, Teddington, UK) were 
cultured in RPMI-1640 medium containing 20% fetal calf serum, 4mM L-glutamine (Seromed, 
Berlin, Germany), 1% non-essential amino acid and 0.1mg/ml gentamycine. For experiments, 
cells were cultured in DMEM/F12 medium with 1% fetal calf serum and 0.1mg/ml gentamycine. 
Cells were maintained in a humidified incubator at 37°C and 5% CO2 atmosphere.  
2.1.6. Chemicals and reagents 
Chemical or reagent                          Manufacturer                           
Agarose  
APS  
Acrylamide  
Acetic acid  
Bromophenol blue  
BSA  
Buffer B 10 X 
Collagen A 
DMEM/F12 medium  
DMSO  
DEPC water  
DMEM red-free medium 
dNTPs  
EDTA  
FCS 
Gentamycine  
Glycerol  
Glycine  
HCl 
L-glutamine  
Carl Roth GmbH, Karlsruhe, Germany 
Carl Roth GmbH, Karlsruhe, Germany 
Carl Roth GmbH, Karlsruhe, Germany 
Carl Roth GmbH, Karlsruhe, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
New England BioLabs, Frankfurt, Germany 
Solis BioDyne, Tartu, Estonia 
Biochorm, Berlin, Germany 
PAA, Coelbe, Germany 
Carl Roth GmbH, Karlsruhe, Germany 
Carl Roth GmbH, Karlsruhe, Germany 
Gibco, Carlsbad, California,USA 
Solis BioDyne, Tartu, Estonia 
Bioproducts, Ingelheim, Germany 
PAA, Coelbe, Germany 
PAA, Coelbe, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
Carl Roth GmbH, Karlsruhe, Germany 
PAA, Coelbe, Germany 
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Methanol  
MgCl2 
NP-40 
Non-essential amino acids 
PBS 
Propofol 
Phosphatase inhibitor cocktail tablets 
Sigma-Aldrich, Schnelldorf, Germany 
Solis BioDyne, Tartu, Estonia 
Sigma-Aldrich, Schnelldorf, Germany 
PAA, Coelbe, Germany 
PAA, Coelbe, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
Roche, Mannheim, Germany 
Protease inhibitor cocktail tablets 
RPMI-1640 medium 
Roti®-safe gel stain 
Sodium chloride 
Sodium deoxycholate 
Sodium azide 
SDS 
Starting blockTM T20 blocking buffer 
Trypsin/EDTA  
Trypan-blue 
Roche, Mannheim, Germany 
PAA, Coelbe, Germany 
Carl Roth GmbH, Karlsruhe, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
Sigma-Aldrich, Schnelldorf, Germany 
Thermo, Rockford, USA 
Bioproducts, Ingelheim, Germany  
Sigma-Aldrich, Schnelldorf, Germany 
Triton X -100                Sigma-Aldrich, Schnelldorf, Germany 
Tris-HCl                          Sigma-Aldrich, Schnelldorf, Germany 
TEMED                                Sigma-Aldrich, Schnelldorf, Germany 
Tween 20                        Roche, Mannheim, Germany 
Tris                              Carl Roth GmbH, Karlsruhe, Germany
β-mercaptoethanol                  Carl Roth GmbH, Karlsruhe, Germany
2’7’-dichlorodihydrofluorescein diacetate Sigma-Aldrich, Schnelldorf, Germany 
6 X DNA loading dye            Fermentas Inc., Maryland, USA 
DNA ladder                   Fermentas Inc., Maryland, USA 
 
2.1.7. Solutions 
                                                                               
4 X Laemmli buffer: 2.5ml 1M Tris pH 6.8, 0.8g SDS, 2ml β-mercaptoethanol, 4ml glycerol, 
0.1ml 1% bromophenol blue, filled up to 10ml with DD water. 
Resolving gel buffer: 45.42g Tris, 1g SDS, filled up to 250ml with DD water, pH 8.8.
Stacking gel buffer: 15.14g Tris, 1g SDS, filled up to 250ml with DD water, pH 6.8.
Running buffer: 12.2g Tris, 57.6g glycine, 4g SDS, filled up to 4L with DD water.
Transfer buffer: 28.6g glycine, 24.2g Tris, 0.4L methanol, filled up to 2.4L with DD water.
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TBST buffer: 6.06g Tris, 20.25g sodium chloride, 5ml 0.5M EDTA, 2.5ml Tween 20, filled up to 
2.5L with DD water, pH 7.5.
50 X TAE buffer: 242g Tris, 57.1ml acetic acid, 100ml 0.5M EDTA, filled up to 1L with DD 
water, pH 8.0.
RIPA buffer: 4.38g sodium chloride, 5ml NP-40, 3.03g Tris, 5g sodium deoxycholate, 5ml 10% 
SDS stock solution, filled up to 500ml with DD water, pH 7.6.
Phosphatase inhibitor solution: 1 tablet of phosphatase inhibitor, 1ml DD water, filtered before 
use.
Protease inhibitor solution: 1 tablet of protease inhibitor, 2ml DD water, filtered before use.
RIPA complete buffer: 5ml phosphatase inhibitor solution, 4ml protease inhibitor solution, filled 
up to 50ml with RIPA buffer.
2.1.8. Consumables 
Cell culture flasks, 96-well plates and falcon tubes were purchased from Greiner bio-one GmbH 
(Frickenhausen, Germany); eppendorf tubes and pipette tips were purchased from Eppendorf 
(Cologne, Germany); serological pipettes were purchased from Sarstedt (Nümbrecht, Germany); 
PVDF membranes and Hyperfilm ECL were purchased from Amersham Pharmacia Biotech 
(Piscataway, USA); nitrocellulose membranes were purchased from Sigma-Aldrich (Schnelldorf, 
Germany). 
2.1.9. Instruments 
Instrument                                 Manufacturer                            
Thermocycler T Gradient                     Biometra, Göttingen, Germany 
Darkroom cabinet Evo III                      Raytest, Straubenhardt, Germany 
Electrophoresis chamber 40-1214               Peqlab, Erlangen, Germany 
Incubator Heraeus                           Kendro, Hanau, Germany 
Tissue culture incubator Hera Cell              Kendro, Hanau, Germany 
Orbital Shaking Incubator S150               Bibby Sterilin, Staffordshire, UK 
Photometer Genesys                        ThermoSpectronic, Germany 
Centrifuge Sorvall Super T21                 Kendro, Hanau, Germany 
Centrifuge Biofuge fresco                    Kendro, Hanau, Germany 
Rotator Intelli-Mixer                Neo-lab, Heidelberg, Germany 
Mini-Trans-BlotCell             Bio-Rad, München, Germany 
Tissue oxygen pressure monitor     Integra, Plainsboro, USA 
Bright field microscope             Leica, DMIL, Germany
 
 
14 
 
ELISA reader                     Tecan, Crailsheim, Austria 
Fluorescence ELISA reader (Genios FL)   Tecan, Crailsheim, Austria 
Bandelin SONOREX RK 106S         Schalltec, Mörfelden-Walldorf, Germany 
Eppendorf single-channel pipettes Eppendorf AG, Hamburg, Germany
Handy step repeating pipette                   Brand GmbH, Wertheim, Germany 
Charge-coupled device camera      Raytest GmbH, Straubenhardt, Germany 
 
2.1.10.  Software 
XnView v1.95.4 was used to take pictures from cells. Images of RT-PCR and western blotting 
experiments were analyzed with ImageJ (v1.41o, NIH). ELISA reader and fluorescence ELISA 
reader were combined with the Magellan software v1.1. Statistics were performed using 
GraphPad Prism version 5.01 for Windows. 
2.2. Methods 
 
2.2.1. Experimental setting 
In vitro hypoxia was induced by our recently described enzymatic system (Zitta et al. 2012a, 
Zitta et al. 2012b, Zitta et al. 2010a, Zitta et al. 2010b) in combination with nitrocellulose 
membranes (Huang et al. 2012, Zitta et al. 2010b). Membranes were co-incubated with culture 
medium for 60min. During this time, partial pressure of oxygen (pO2) rapidly decreases to levels 
lower than 5mmHg which is defined as hypoxia (Wilensky et al. 2005). During hypoxia, culture 
flasks were additionally filled with nitrogen and closed tightly. PO2 was measured by a tissue 
oxygen pressure monitor (LICOX® CMP Oxygen Catheter; Integra) (Fig.5).  
 
 
Figure 5: PO2 was measured by a tissue oxygen pressure monitor LICOX® CMP Oxygen Catheter. 
 
 
15 
 
Cells were maintained in hypoxic medium for 2h. Hypoxia was terminated by the addition of 
fresh oxygenated culture medium. This step represents the reoxygenation phase in vivo. All 
molecular, biochemical and cellular analyses were performed with samples taken during the 
reoxygenation phase (Fig.6). Stimulations were performed with anaesthetic concentrations of 
propofol (30μM) dissolved in DMSO. Briefly, a stock solution I of 250mM propofol was 
prepared in DMSO and diluted 1:100 with the respective cell culture medium to achieve a 
2.5mM propofol stock solution II. The working solution of propofol (30µM) was then prepared 
by diluting the stock solution II 1:83 with the respective cell culture medium. Therefore, the final 
concentration of DMSO in the working solution was 0.012%. Controls were performed by 
adding DMSO at a final concentration of 0.012%, which does not affect gene expression, cell 
proliferation or apoptosis (Adler et al. 2006, Nishimura et al. 2008, Santos et al. 2003).  
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Figure 6: Experimental setting and time frame. 
 
2.2.2. Cell culture 
IMR-32 neuroblastoma cells were propagated in RPMI-1640 medium supplemented with 20% 
fetal calf serum, 4mM L-glutamine, 1% non-essential amino acid and 0.1mg/ml gentamycine. As 
high concentrations of fetal calf serum may affect the LDH and hydrogen peroxide 
measurements, DMEM/F12 medium containing 1% fetal calf serum was used for all experiments. 
Cells were cultured in a humidified incubator at 37°C and 5% CO2. Confluent cells were 
detached by trypsinization (0.025% trypsin-1mM EDTA) at 37°C. Cell numbers were evaluated 
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with a hemocytometer and viability was assayed by the trypan-blue dye exclusion technique. 
Cell morphology was evaluated by bright field microscopy. 
2.2.3. Reverse transcription polymerase chain reaction (RT-PCR) 
 
2.2.3.1. RNA extraction  
Cells were washed once with pre-warmed PBS before RNA isolation, lysed in 600μl RLT buffer 
and then well mixed with 600μl ethanol. The Qiagen RNeasy mini kit in combination with the 
manufacturer’s protocol was employed to isolate RNA. For measuring the concentration, isolated 
RNA was diluted 100 times in DD water. 
2.2.3.2. Reverse transcription 
A spectrophotometer was used to measure the RNA concentrations. The purity of the isolated 
RNA was evaluated by the ratio of 260/280nm. 200ng RNA diluted in 10μl DEPC water was 
transcribed to cDNA using a reverse transcription kit with random hexamer primers. 20μl 
reaction mix was prepared as follows: 2μl RT buffer 10 X, 0.8μl 100mM dNTPs Mix, 2μl 
random primers 10 X, 1μl 50U/μl reverse transcriptase, 1μl 20U/μl RNase inhibitor, 3.2μl DEPC 
water, 200ng RNA diluted in 10μl DEPC water. 
The reverse transcription program was set as follows: 
10min  
 
 
2h 
25 °C  
 
 
37 °C 
5s 
 
30s 
85 °C 
 
72 °C 
                    ∞                              4 °C 
Transcribed samples were stored at -20 °C until use. 
 
2.2.3.3. Polymerase chain reaction 
2μl cDNA was used for the polymerase-chain reaction. 1μl of forward and reverse primers were 
used for specific fragment amplification. 20μl reaction mixture was prepared as follows: 2μl 
Buffer B 10 X, 1μl 16mM dNTPs Mix, 3μl 5mg/ml BSA, 1.6μl 25mM MgCl2, 0.5μl 5U/μl Taq 
Polymerase, 7.9μl DEPC water, 2μl cDNA, 1μl forward primer and 1μl reverse primer. 
The amplification was performed in a thermocycler using the following program: 
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40 cycles: 
15min 
 
 
 
30s 
95 °C 
 
 
 
95 °C 
 30s 
 
30s 
55-62 °C 
 
72 °C 
  
10min 
 
∞ 
 
72 °C 
 
4 °C 
The PCR amplification products and DNA ladder were diluted in 6 X loading buffer and then 
separated on 2.5% agarose gels containing 0.005% Roti®-Safe gel stain. Bands were visualized 
using UV-transilumination. Images were taken with a charge-coupled device camera in 
combination with the Diana v1.6 program and analyzed with the ImageJ (v1.41o, NIH) software. 
2.2.4. Cytotoxicity assay 
LDH released into the medium was measured by a colorimetric cytotoxicity detection assay kit. 
Samples were prepared following the manufacturer’s protocol. The culture medium was 
collected 24h after hypoxia and stored at -20°C. For evaluation of the total LDH, cells were lysed 
with 2% Triton X -100 and incubated for 15min at 37°C. LDH activity in culture medium 
without contacting to cells was used as background control. 100μl of each sample was 
transferred into 96-well plates and mixed with 100μl detection solution. Samples were measured 
in 96-well plates at 492nm using an ELISA reader in combination with the Magellan software 
v1.1. 
2.2.5. Western blotting 
 
2.2.5.1. Total protein extraction and quantification  
300μl ice cold RIPA complete buffer was used to lyse the cells. The mixture was then sonicated 
for 15min on ice and centrifuged at 10,000 rpm for 10min at 4°C. The supernatant was collected 
for protein quantification using Roti®-Quant assays. 200μl prepared Roti®-Quant detection 
solution was mixed with the 50μl supernatant and incubated at room temperature for 5min. 
Samples were measured at 620nm using an ELISA reader. Absorbance was converted to protein 
concentration using Roti®-Quant assay standard curve (see appendix 7.1.).  
2.2.5.2. Electrophoresis 
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30μg total protein diluted in 7.5μl RIPA complete buffer was mixed with 2.5μl 4 X Laemmli 
buffer and heated for 3min at 95°C before loading. The mixture was then separated by 10% 
SDS-PAGE at constant 120V for 1.5h. SDS-Polyacrylamide gel (10%) preparation was 
performed as follows: 
Stacking gel: 2.6ml stacking gel buffer, 1.13ml acrylamid, 6.19ml DD water, 60μl 10% APS, 
30μl TEMED. 
Resolving gel: 2.6ml resolving gel buffer, 2.5ml acrylamid, 4.81ml DD water, 60μl 10% APS, 
30μl TEMED. 
           
2.2.5.3. Transfer 
The proteins in the gels were transferred at constant 400mA for 1.5h to PVDF membranes. For 
activation, the PVDF membranes were maintained in methanol for 15s, rinsed in DD water and 
equilibrated in transfer buffer for at least 10min before use. 
2.2.5.4. Blocking and antibody incubation 
After transfer, the PVDF membranes were incubated in blocking solution for 1h at room 
temperature, and then co-incubated with the appropriate dilutions of primary antibody over night 
at 4°C. Primary antibodies were directed against catalase (Abcam; 1:15,000), caspase-3 (Santa 
Cruz; 1:200) and β-actin (Santa Cruz; 1:1,000). Membranes were then washed in TBST buffer 3 
times for 10min and incubated for 1h with the secondary HRP coupled- antibody, anti-rabbit 
(IgG-HRP) or rabbit anti-goat (IgG-HRP). After washing in TBST buffer, the membranes were 
finally incubated with ECL detection reagent for 5 min. For chemiluminescent detection, the 
membranes were exposed to autoradiography films in the dark. Relative intensities of the protein 
bands were analyzed by ImageJ (v1.410, NIH).  
2.2.6. H2DCFDA assay 
10,000 cells per well were seeded into collagen-coated 96-well black plates. After being cultured 
for 72h, cells were washed with pre-warmed PBS and maintained in a phenol red-free medium 
with 1% fetal calf serum until 15h after hypoxia/reoxygenation. Intracellular reactive oxygen 
species were measured by adding 2’7’-dichlorodihydrofluorescein diacetate (H2DCFDA) which 
is oxidized to fluorescent dichlorofluorescein (DCF) by intracellular reactive oxygen species at a 
final concentration of 10μM. DCF-loaded cells were then kept in the dark and were immediately 
placed in a fluorescence ELISA reader at 37°C. Fluorescence was measured at an excitation 
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wavelength of 485 nm and an emission wavelength of 535nm. Data were obtained at 0min and 
30min. The increase of fluorescence per well was calculated by the formula: (Ft30- Ft0)/Ft0* 
100, where Ft30= fluorescence at 30 min and Ft0= fluorescence at 0 min (Wang et al. 1999). 
2.2.7. Hydrogen peroxide assay 
Hydrogen peroxide levels were measured with a QuantiChromTM peroxide assay kit. Supernatant 
from culture medium was collected 15h after hypoxia and stored at -20°C. Samples (20μl) were 
prepared in 96-well plates following the manufacturer’s protocol. The culture medium that was 
not in contact with cells was used as background control. Absorbance was measured at 610nm 
using an ELISA reader in combination with the Magellan software v1.1. The hydrogen peroxide 
concentration standard curve is shown in the appendix (7.2.). 
2.2.8. Catalase activity assay 
Cells were detached by a rubber policeman and then centrifuged at 2,000rpm for 10 minutes at 
room temperature. The cell pellet was homogenized on ice in 300μl cold PBS containing 1mM 
EDTA and then centrifuged at 10,000rpm for 15min at 4°C. The supernatant was removed and 
the protein concentration was quantified with a Roti®-Quant assay. Samples were stored at 
-80°C. Catalase activity was estimated with the QuantiChromTM peroxide assay kit by measuring 
the hydrogen peroxide left over in each sample. Briefly, catalase was dissolved in water and the 
following standards were prepared: 50 Units/ml, 25 Units/ml, 12.5 Units/ml, 6.25 Units/ml, 
3.125 Units/ml, 1.563 Units/ml and 0 Units/ml. 20μl of each sample containing 1.25μg protein 
and catalase standards were transferred to 96-well plates for measuring. To start the reaction, 
20μl of hydrogen peroxide (150μM) solution was added to each well followed by a 10min 
incubation at room temperature. For the detection of catalase activity, 200μl detection reagent 
(prepared as described by the manufacturer’s protocol) was added to each well. Plates were 
incubated at room temperature for 30min and absorbance was read at 610nm using an ELISA 
reader (Tecan). Catalase activity in the samples was calculated from the standard curve (see 
appendix 7.3.). 
2.2.9. Statistics 
All experiments were independently performed 3-4 times using at least duplicated samples. 
Statistics were performed with the statistic software GraphPad Prism version 5.01 for Windows. 
For normalization, all data were transformed using arcsin√X to allow the subsequent use of 
parametric test. Data were then analysed by one-way analysis of variance, and in cases of 
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significant differences, adjusted for multiple comparisons (Tukey). Variables are expressed as 
means ± S.D. 
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3. Results 
 
3.1. Induction of in vitro hypoxia 
Employing the two-enzyme hypoxia system and the previously described experimental setting, 
partial pressure of oxygen (pO2) in the culture medium was reduced to levels below 5 mmHg 
within10 min and could be maintained at steady-state levels for up to at least 4h (Fig.7). 
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Figure 7: Induction of in vitro hypoxia. Partial pressure of oxygen (pO2) is rapidly reduced in the culture medium utilizing the 
two-enzyme hypoxia system and kept at a steady-state level for up to 4 h. Bars denote S.D. 
 
3.2. Effects of propofol on hypoxia induced cell damage 
RT-PCR results showed that addition of propofol significantly reduced the mRNA expression of 
caspase-3 (hypoxia: 0.23±0.08 a.u.; hypoxia + propofol: 0.04±0.05 a.u.; P<0.05) whereas the 
expression of bax and bcl-2 was not significantly influenced by the addition of propofol (Fig.8 A). 
Although gene expression of caspase-3 was regulated by propofol, evaluation of protein levels of 
inactive pro-caspase-3 and active caspase-3 did not show any differences among the groups 
(pro-caspase-3 hypoxia: 1.42±0.04 a.u., pro-caspase-3 hypoxia + propofol: 1.51±0.12 a.u. 
pro-caspase-3 normoxia control: 1.47±0.14 a.u.; active-caspase-3 hypoxia: 0.64±0.08 a.u., 
active-caspase-3 hypoxia + propofol: 0.64±0.05 a.u., active-caspase-3 normoxia control: 
0.57±0.04 a.u.; P>0.05; Fig.8 B). Nevertheless, morphologically, IMR-32 cells that received 
propofol before and during hypoxia showed reduced signs of cell damage such as cell rounding 
and detachment of the growth surface (Fig.8 C). This observation was also confirmed by the 
evaluation of released LDH as a marker for cell damage. Hypoxia increased the release of LDH 
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(hypoxia: 0.78±0.21 a.u., normoxia control: 0.39±0.07 a.u.; P<0.05) and addition of propofol 
reduced the hypoxia-mediated cell damage (hypoxia + propofol: 0.44±0.17 a.u.; P<0.05 vs 
hypoxia; Fig.8 D). 
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Figure 8: Effects of hypoxia and propofol on gene expression and cell damage. (A) Gene expression of bax, bcl-2 and caspase-3. 
Images of one representative PCR experiment are shown above the columns. (B) Protein expression of pro-caspase-3 and 
active-caspase-3. No significant differences are observed among the groups. One representative western blot is shown on the right. 
(C) Morphological signs of cell damage (e.g. cell shrinking, rounding and detachment from the growth surface) are observed 15h 
after hypoxia and reduced by the addition of propofol. (D) Lactate dehydrogenase (LDH) assays show that cell damage is 
increased by hypoxia and attenuated after addition of propofol. Bars in the photomicrographs denote 50μm. Columns show the 
mean of 3 independent experiments. Bars denote S.D.; *P<0.05; H,    = hypoxia; HP,    = hypoxia+propofol; NC,    = 
normoxia control. Taken from: Huang et al., 2012. 
 
 
3.3. Effects of propofol on hypoxia induced generation of reactive oxygen species 
H2DCFDA assays were performed to evaluate the influence of hypoxia and propofol on the 
generation of intracellular reactive oxygen species. Hypoxia increased intracellular reactive 
oxygen species (hypoxia: 267.70±28.91 a.u., normoxia control: 206.60±27.99 a.u.; P<0.01) and 
addition of propofol significantly reduced the generation of reactive oxygen species (hypoxia + 
propofol: 234.00±33.39 a.u.; P<0.05 vs hypoxia Fig.9).  
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Figure 9: Production of reactive oxygen species. Intracellular reactive oxygen species were measured using 
2’7’-dichlorodihydrofluorescein diacetate which is cleaved by esterases and is oxidized to fluorescent dichlorofluorescein (DCF). 
Propofol reduces the hypoxia induced increase of reactive oxygen species. Ft0 = fluorescence at 0min, Ft30 = fluorescence at 
30min. Columns show the mean of 4 independent experiments. Bars denote S.D.;* P<0.05, ** P<0.01. Taken from: Huang et al., 
2012. 
 
 
3.4. Effects of propofol on hypoxia induced generation of hydrogen peroxide 
Hydrogen peroxide assays were used to measure the release of hydrogen peroxide into the 
culture medium. The concentrations of hydrogen peroxide in the culture medium were 
significantly increased 15h after hypoxia (hypoxia: 17.38±2.70 µM, normoxia control: 1.68±0.14 
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µM; P<0.001) while addition of propofol resulted in diminished levels of hydrogen peroxide 
(hypoxia + propofol: 13.22±1.29 µM; P<0.05 vs hypoxia; Fig.10). 
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Figure 10: Release of hydrogen peroxide into the culture medium. Propofol attenuates the hypoxia induced increase of hydrogen 
peroxide. Columns show the mean of 3 independent experiments. Bars denote S.D.;* P<0.05, *** P<0.001. Taken from: Huang 
et al., 2012. 
 
3.5. Effects of propofol on hypoxia regulated expression and activity of catalase 
Catalase regulates the decomposition of hydrogen peroxide to water and oxygen and therefore 
plays a central role in hydrogen peroxide metabolism. Gene expression of catalase was slightly 
reduced by the addition of propofol (hypoxia: 0.20±0.04 a.u., hypoxia+propofol: 0.11±0.12 a.u.; 
P>0.05; Fig.11 A). Western blotting results showed increased amounts of catalase under hypoxic 
conditions (hypoxia: 1.29±0.04 a.u., normoxia control: 0.92±0.04 a.u.; P<0.001) and addition of 
propofol decreased the amount of catalase protein (hypoxia + propofol: 1.04±0.03 a.u.; P<0.01 
vs hypoxia; Fig.11 B). Interestingly, measurements of catalase activity revealed a statistically 
significant increase in the enzymatic activity after addition of propofol (hypoxia: 2.45±0.46 U/ml, 
hypoxia+propofol: 5.17±1.68 U/ml; P<0.05; Fig.11 C). 
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Figure 11: Gene expression, protein expression and activity of catalase. (A) Catalase gene expression was evaluated by RT-PCR. 
(B) Catalase protein levels were quantified by western blotting 15h after hypoxia and normoxia, respectively. Compared to 
hypoxia, the amount of catalase protein is reduced after addition of propofol. (C) Intracellular catalase activity was evaluated by 
catalase assays. Addition of propofol increases the enzymatic activity of catalase in IMR-32 cells. Columns show the mean of 3 
independent experiments. Bars denote S.D.; * P<0.05, ** P<0.01, *** P<0.001. Taken from: Huang et al., 2012. 
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4. Discussion 
4.1. Induction of in vitro hypoxia 
Cellular models have been proven to be an efficient way to study hypoxia/reoxygenation injury 
(Watkins et al. 1995). There are several ways to induce oxygen deficiency in cell culture systems. 
Some researchers utilized sodium dithionite (Huang et al. 2009, Zheng et al. 2003) to 
reduce the levels of dissolved oxygen in culture medium. However, addition of sodium 
dithionite causes an exothermic reaction which generates sodium sulfite and toxic sulfur 
dioxide resulting in serious side effects during the induction of hypoxia. Cobalt chloride was 
used to induce hypoxia in cell culture as well (Law et al. 2012, Saxena et al. 2012). However, 
cobalt is a heavy metal and therefore predisposes tissue and cells to poisoning. One of the most 
commonly used systems for reducing oxygen levels in cell culture is the hypoxic chamber which 
utilizes a sealed chamber with an adjustable gas mixture system composed mostly of 95% N2 and 
5% CO2 (Lievre et al. 2000). Nevertheless, a disadvantage of this hypoxic chamber is that the 
generation of hypoxia is a very slow process which can last up to 24h (Allen et al. 2001). 
Moreover, as the hypoxic chamber is a sealed system, interventions are difficult to perform. 
In contrast to the hypoxic chamber, in the enzymatic system employed here, stable hypoxia is 
established rapidly within minutes, and terminated by the addition of fresh oxygenated culture 
medium ((Zitta et al. 2012a, Zitta et al. 2012b, Zitta et al. 2010a, Zitta et al. 2010b). Moreover, 
glucose is gradually and physiologically depleted from the medium, which leads to glucose 
deficiency as it is also observed under ischemic conditions in vivo. Therefore, the two-enzyme 
hypoxia system is an ideal model to investigate mechanisms that are associated with clinical 
hypoxia/reoxygenation injury such as stroke, myocardial infarction and cerebral or intestinal 
ischemia. 
4.2. Effects of propofol on hypoxia induced cell damage 
Hypoxia and reoxygenation are a crucial events in physiological as well as pathophysiological 
processes and numerous clinical conditions are associated with hypoxia /reoxygenation (Li et al. 
2002). Especially in the brain, intra- or peri-operative ischemia can lead to 
hypoxia/reoxygenation injury which is associated with severe neuronal cell damage (Dominguez 
et al. 2007, Gazzolo et al. 2009). Propofol, a short-acting intravenous anaesthetic, has been 
shown to protect neuronal cells from hypoxia/reoxygenation injury. Nevertheless, the detailed 
cellular and molecular mechanisms of the protective effects of propofol are still under 
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discussion.  
In the study presented, hypoxia significantly increased the damage of IMR-32 cells (LDH 
measurements, cell morphology), but did not change the activity of caspase-3 which is a key 
effector molecule in apoptosis (Riedl et al. 2004). Anaesthetic doses of propofol (30µM; Spelina 
et al. 1986, Turtle et al. 1987) decreased the hypoxia /reoxygenation induced cell damage 
without attenuating caspase-3 activity. Similar results have been obtained by Tu et al. who 
investigated the effects of propofol on neuropathogenesis in newborn rats under hypoxic 
conditions and showed that neither propofol nor hypoxia did influence apoptosis (Tu et al. 2011). 
Employing the neuroblastoma cell line SH-SY5Y, Wu et al. demonstrated that 10µM propofol 
improved cell proliferation and inhibited dynorphin A induced cytotoxicity (Wu et al. 2011), an 
observation that is in concordance with our in vitro results obtained with 30µM propofol. Also 
other authors have shown protective effects of propofol in different experimental systems 
(Acquaviva et al. 2004, Ishii et al. 2002, Scapagnini et al. 2002, Wang et al. 2002). 
4.3. Effects of propofol on hypoxia induced generation of reactive oxygen species and 
hydrogen peroxide 
Generation of reactive oxygen species is a significant component in hypoxia/reoxygenation 
induced cerebral damage (Olmez et al. 2012). According to the previous studies, propofol has 
been shown to be not only an efficient neuroprotective reagent but also a potent antioxidant. 
Several studies propose that the rise in intracellular reactive oxygen species is due to a loss of the 
mitochondrial membrane potential (Ψm) by the absence of oxygen. Under physiological 
conditions, the mitochondrial membrane is polarized and has a Ψm, which is maintained by ATP 
and proton gradients across the membrane. These gradients are in turn dependent on oxygen 
availability. Maintenance of Ψm keeps proteins such as cytochrome C and reactive oxygen 
species within the confines of the mitochondria. Periods of hypoxia on the other hand disturb the 
proton gradients and have the potential to reduce Ψm which in turn results in an increase of 
reactive oxygen species in the cytoplasmic compartment (Li et al. 2002, Millar et al. 2007).  
Hypoxia/reoxygenation injury is associated with a generation of reactive oxygen species which 
have various mostly deleterious effects on the affected tissue (Chi et al. 2010, Razorenova 2012, 
Tan et al. 1999). Several authors suggested that cerebral hypoxia/reoxygenation leads to 
cytotoxic damage and that these events can be attenuated by the antioxidant activity of propofol 
(Budic et al. 2010, De La Cruz et al. 1998). In our study, we showed that compared to normoxic 
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conditions, reactive oxygen species and hydrogen peroxide concentrations are increased under 
hypoxia and that this effect is significantly attenuated by the addition of propofol. Similar results 
were shown by Hsing et al. who used CM-H2DCFDA assays to investigate intracellular reactive 
oxygen species and demonstrated that anaesthetic doses of propofol had anti-inflammatory 
effects by regulating reactive oxygen species mediated PKB and NF-κB signaling in vitro and in 
vivo (Hsing et al. 2011). 
4.4. Effects of propofol on hypoxia regulated expression and activity of catalase 
Although our findings confirm the above-mentioned studies suggesting antioxidant properties of 
propofol being at least partly responsible for the observed neuroprotective effects, they do not 
verify whether direct antioxidant effects of propofol mediated by its phenolic chemical structure, 
indirect actions of propofol (e.g. induction of an antioxidant response in the target cells) or a 
combination of both are responsible for the antioxidant activity of the anaesthetic. 
Under physiological conditions, cytoplasmic reactive oxygen species are scavenged by SOD, 
GPX, CAT as well as other small molecular antioxidants, including glutathione, ascorbic acid 
and α-tocopherol. These endogenous antioxidants are unable to cope with the excess of reactive 
oxygen species generated during hypoxia/reoxygenation, resulting in an increased oxidation of 
macromolecules (e.g. lipids, proteins and nucleic acids) and cell damage (Sugawara et al. 2003). 
Catalase catalyzes the decomposition of hydrogen peroxide to water and oxygen and may 
therefore be a potential candidate for indirect target cell mediated cytoprotective effects of 
propofol (Giorgio et al. 2007). Our western blotting experiments showed a reduction of the 
amount of catalase protein in IMR-32 cells after the addition of propofol under hypoxic 
conditions. Nevertheless, the activity measurements revealed an increased catalase activity in the 
cells. These results point towards a possible augmentation of the catalytic function by direct 
interactions of the anaesthetic with the catalase molecule. 
Another explanation for our findings might be based on the fact that the catalase activity assay 
employed in this study uses hydrogen peroxide as substrate and may therefore also detect other 
hydrogen peroxide degrading peroxidases. Propofol may indeed increase the activities of other 
hydrogen peroxide degrading enzymes. This has also been demonstrated by groups that detected 
elevated activities of glutathione peroxidase in serum and plasma of pigs and adult patients 
during propofol anaesthesia (Abou-Elenain 2010, Allaouchiche et al. 2001).  
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5. Summary 
Background: Propofol, a widely used intravenous anaesthetic agent, has been shown to protect 
neuronal cells from hypoxia/reoxygenation injury. However, the underlying mechanisms of these 
neuroprotective effects are still unclear but may be related to reactive oxygen species which are 
produced during hypoxia/reoxygenation induced injury. Aim of the study was to investigate the 
molecular and cellular effects of propofol on hypoxia-induced cell-damage employing the 
neuronal cell line IMR-32.  
Results: Hypoxia led to morphological signs of cell damage and increased the release of LDH 
(hypoxia: 0.78±0.21 a.u., normoxia: 0.39±0.07 a.u.; P<0.05). Addition of propofol significantly 
reduced the hypoxia induced LDH release (hypoxia + propofol: 0.44±0.17 a.u.; P<0.05 vs 
hypoxia), diminished morphological signs of cell damage but did not influence protein levels of 
caspase-3. Reactive oxygen species were increased under hypoxic conditions and significantly 
reduced by the addition of propofol (hypoxia: 267.70±28.91 a.u., normoxia: 206.60±27.99 a.u.; 
P<0.01; hypoxia + propofol: 234.00±33.39 a.u.; P<0.05 vs hypoxia). Addition of propofol also 
decreased hydrogen peroxide levels (hypoxia: 17.38±2.70 µM, hypoxia + propofol: 13.22±1.29 
µM; P<0.05). Western blotting experiments showed increased amounts of catalase under hypoxic 
conditions (hypoxia: 1.29±0.04 a.u., normoxia: 0.92±0.04 a.u.; P<0.001). Addition of propofol 
decreased the amount of catalase (hypoxia + propofol: 1.04±0.03 a.u.; P<0.01 vs hypoxia) but 
increased enzymatic activity of the protein (hypoxia: 2.45±0.46 U/ml, hypoxia + propofol 
5.17±1.68 U/ml; P<0.05). 
Conclusion: We suggest that propofol protects neuronal cells from hypoxia/reoxygenation injury 
and that the associated events may besides direct antioxidant actions of propofol also be due to 
the capability of the anaesthetic to induce cellular antioxidant mechanisms. 
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7. Appendix 
 
7.1. Standard curve of Roti®-Quant assays 
 
7.2. Standard curve of hydrogen peroxide assays 
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7.3. Standard curve of catalase activity assays 
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